CORC  > 江苏大学
KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
Zhou, Jing-Dong[1]; Yao, Dong-Ming[2]; Li, Xi-Xi[3]; Zhang, Ting-Juan[4]; Zhang, Wei[5]; Ma, Ji-Chun[6]; Guo, Hong[7]; Deng, Zhao-Qun[8]; Lin, Jiang[9]; Qian, Jun[10]
刊名ONCOTARGET
2017
卷号8期号:39页码:66087-66097
关键词RAS expression mutation prognosis acute myeloid leukemia
ISSN号1949-2553
DOIhttp://dx.doi.org/10.18632/oncotarget.19798
URL标识查看原文
收录类别SCI(E) ; PUBMED
WOS记录号WOS:000410291200113
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5349253
专题江苏大学
作者单位1.[1]Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China.
2.Key Lab Precis Diag & Treatment Zhenjiang City, Zhenjiang, Jiangsu, Peoples R China.
3.[2]Jiangsu Univ, Affiliated Peoples Hosp, Lab Ctr, Zhenjiang, Jiangsu, Peoples R China.
4.Key Lab Precis Diag & Treatment Zhenjiang City, Zhenjiang, Jiangsu, Peoples R China.
5.[3]Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China.
6.Key Lab Precis Diag & Treatment Zhenjiang City, Zhenjiang, Jiangsu, Peoples R China.
7.[4]Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China.
8.Key Lab Precis Diag & Treatment Zhenjiang City, Zhenjiang, Jiangsu, Peoples R China.
9.[5]Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China.
10.Key Lab Precis Diag & Treatment Zhenjiang City, Zhenjiang, Jiangsu, Peoples R China.
推荐引用方式
GB/T 7714
Zhou, Jing-Dong[1],Yao, Dong-Ming[2],Li, Xi-Xi[3],et al. KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia[J]. ONCOTARGET,2017,8(39):66087-66097.
APA Zhou, Jing-Dong[1].,Yao, Dong-Ming[2].,Li, Xi-Xi[3].,Zhang, Ting-Juan[4].,Zhang, Wei[5].,...&Qian, Jun[10].(2017).KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia.ONCOTARGET,8(39),66087-66097.
MLA Zhou, Jing-Dong[1],et al."KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia".ONCOTARGET 8.39(2017):66087-66097.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace